Published in Proc Natl Acad Sci U S A on December 01, 1988
The IL-1 family: regulators of immunity. Nat Rev Immunol (2010) 4.65
A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect Immun (1995) 1.99
Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J Exp Med (1990) 1.81
Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution. Infect Immun (1990) 1.55
The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal (2012) 1.47
Impaired interleukin 4 signaling in T helper type 1 cells. J Exp Med (1998) 1.41
Th2 cell clonal anergy as a consequence of partial activation. J Exp Med (1994) 1.34
Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection. Infect Immun (1994) 1.21
Downregulation of CD40 ligand response in monocytes from sepsis patients. Clin Vaccine Immunol (2008) 1.20
CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite. J Exp Med (1994) 1.17
CD28-induced costimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin 4. J Exp Med (1993) 1.16
Purification of a factor which provides a costimulatory signal for gamma interferon production. Infect Immun (1993) 1.14
Th2 signals induce epithelial injury in mice and are compatible with the biliary atresia phenotype. J Clin Invest (2011) 1.13
Type I (insulin-dependent) diabetes is a Th1- and Th2-mediated autoimmune disease. Clin Diagn Lab Immunol (1999) 1.04
Effect of adoptive transfer of cloned Actinobacillus actinomycetemcomitans-specific T helper cells on periodontal disease. Infect Immun (1991) 1.02
Interleukin-1 synergy with phosphoinositide pathway agonists for induction of interleukin-2 gene expression: molecular basis of costimulation. Mol Cell Biol (1990) 1.01
Leishmania major-specific, CD4+, major histocompatibility complex class II-restricted T cells derived in vitro from lymphoid tissues of naive mice. J Exp Med (1993) 0.98
IL-1β suppresses innate IL-25 and IL-33 production and maintains helminth chronicity. PLoS Pathog (2013) 0.96
Expression of the IL-1 receptor discriminates Th2 from Th1 cloned CD4+ T cells specific for Plasmodium chabaudi. Immunology (1994) 0.92
CD4+ murine T cell clones that express high levels of immunoglobulin binding belong to the interleukin 4-producing T helper cell type 2 subset. J Exp Med (1990) 0.90
XOMA 052, a potent, high-affinity monoclonal antibody for the treatment of IL-1β-mediated diseases. MAbs (2011) 0.90
Recombinant interleukin-1 alpha augments granuloma formation and cytokine production but not parasite clearance in mice infected with Leishmania donovani. Infect Immun (1992) 0.88
IL-1 and T Helper Immune Responses. Front Immunol (2013) 0.87
Interleukin-1 down-regulates gene and surface expression of interleukin-1 receptor type I by destabilizing its mRNA whereas interleukin-2 increases its expression. Immunology (1992) 0.87
Regulation of IL-4 lymphokine gene expression and cellular proliferation in murine T helper type II cells. Cell Regul (1990) 0.85
Pattern of proinflammatory cytokine mRNA expression during Trichinella spiralis infection of the rat. Infect Immun (1996) 0.84
Characterization of rat T-cell clones with bacterial specificity. Immunology (1990) 0.83
An in vitro model for infection with Leishmania major that mimics the immune response in mice. Infect Immun (1997) 0.83
Inflammation-induced changes in the phenotype and cytokine profile of cells migrating through skin and afferent lymph. Immunology (1996) 0.83
Inhibition of interleukin-1 beta mRNA expression and interleukin-1 alpha and beta secretion by a specific human recombinant interleukin-1 receptor antagonist in human peripheral blood mononuclear cells. Immunology (1992) 0.82
Eicosapentaenoic acid inhibits antigen-presenting cell function of murine splenocytes. Immunology (1992) 0.82
Differentiation of V beta 8.2+ CD4+ T cells induced by a superantigen: roles of antigen-presenting cells and cytokines. Immunology (1994) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s). J Exp Med (1972) 6.47
Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. J Immunol (1984) 5.51
Interleukin 1: an immunological perspective. Annu Rev Immunol (1985) 4.09
B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells. Proc Natl Acad Sci U S A (1987) 3.33
Heterogeneity of helper/inducer T lymphocytes. I. Lymphokine production and lymphokine responsiveness. J Exp Med (1987) 3.12
Frequencies of IL-2- and IL-4-secreting T cells in naive and antigen-stimulated lymphocyte populations. J Immunol (1988) 2.94
Cloned, Ia-restricted T cells that do not produce interleukin 4(IL 4)/B cell stimulatory factor 1(BSF-1) fail to help antigen-specific B cells. J Immunol (1987) 2.53
T-Cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation. Proc Natl Acad Sci U S A (1981) 2.51
The events of primary T cell activation can be staged by use of Sepharose-bound anti-T3 (64.1) monoclonal antibody and purified interleukin 1. J Immunol (1985) 2.14
Autocrine growth of CD4+ T cells. Differential effects of IL-1 on helper and inflammatory T cells. J Immunol (1988) 2.12
B-cell stimulatory factor 1 and not interleukin 2 is the autocrine growth factor for some helper T lymphocytes. Proc Natl Acad Sci U S A (1987) 1.85
Heterogeneity of helper/inducer T lymphocytes. II. Effects of interleukin 4- and interleukin 2-producing T cell clones on resting B lymphocytes. J Exp Med (1988) 1.76
Interleukin 4 mediates autocrine growth of helper T cells after antigenic stimulation. Proc Natl Acad Sci U S A (1986) 1.51
Interleukin 1-dependent induction of both interleukin 2 secretion and interleukin 2 receptor expression by thymoma cells. J Immunol (1986) 1.49
Capacity of B cells to function as stimulators of a primary mixed leukocyte reaction. J Immunol (1986) 1.40
Interleukin 1 (IL 1)-dependent lymphokine production by human leukemic T cell line HSB.2 subclones. J Immunol (1985) 1.22
Identification of a high-affinity receptor for native human interleukin 1 beta and interleukin 1 alpha on normal human lung fibroblasts. J Exp Med (1987) 1.21
Analysis by in situ hybridization of cells expressing mRNA for interleukin 4 in the developing thymus and in peripheral lymphocytes from mice. Proc Natl Acad Sci U S A (1988) 1.21
Antigen presentation by hapten-specific B lymphocytes. V. Requirements for activation of antigen-presenting B cells. J Immunol (1987) 0.98
Interleukin 1 modulates messenger RNA levels of lymphokines and of other molecules associated with T cell activation in the T cell lymphoma LBRM33-1A5. J Immunol (1987) 0.98
Induction of c-fos and c-myc expression in T lymphocytes after treatment with recombinant interleukin 1-alpha. J Immunol (1986) 0.97
Identification of a high-affinity receptor for interleukin 1 alpha and interleukin 1 beta on cultured human rheumatoid synovial cells. J Clin Invest (1988) 0.87
Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol (1982) 6.05
Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science (1998) 5.19
Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol (1969) 4.93
Retracted Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity (1999) 4.42
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol (1989) 4.30
The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity (1994) 4.26
Interleukin 1: an immunological perspective. Annu Rev Immunol (1985) 4.09
Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity (1997) 4.05
Falciparum malaria-infected erythrocytes specifically bind to cultured human endothelial cells. Science (1981) 3.57
Lateral mobility in membranes as detected by fluorescence recovery after photobleaching. Biophys J (1982) 3.49
Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J Exp Med (1984) 3.36
Heterogeneity of helper/inducer T lymphocytes. I. Lymphokine production and lymphokine responsiveness. J Exp Med (1987) 3.12
Infant botulism. Epidemiological, clinical, and laboratory aspects. JAMA (1977) 3.05
Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity (1998) 3.03
Frequencies of IL-2- and IL-4-secreting T cells in naive and antigen-stimulated lymphocyte populations. J Immunol (1988) 2.94
Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1. J Immunol (1982) 2.90
IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell (1990) 2.86
AIDS: an international perspective. Science (1988) 2.84
Inhibition of B lymphocyte activation by interferon-gamma. J Immunol (1987) 2.80
Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci U S A (1989) 2.73
Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J Immunol (1988) 2.70
Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci U S A (1995) 2.70
Calcium couples flagellar reversal to photostimulation in Chlamydomonas reinhardtii. Nature (1976) 2.67
Intestinal infection and toxin production by Clostridium botulinum as one cause of sudden infant death syndrome. Lancet (1978) 2.60
Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines. Nat Immunol (2001) 2.55
Plasmodium falciparum malaria. An amelanotic melanoma cell line bears receptors for the knob ligand on infected erythrocytes. J Clin Invest (1982) 2.46
Prevention of chronic hepatitis B virus infection from mothers to infants in the United States. Pediatrics (1983) 2.41
CTLA-4 regulates induction of anergy in vivo. Immunity (2001) 2.39
The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice. J Immunol (1988) 2.39
Functional responses and costimulator dependence of memory CD4+ T cells. J Immunol (2000) 2.17
Global surveillance and forecasting of AIDS. Bull World Health Organ (1989) 2.17
The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity (1996) 2.14
Effects of IL-12 on helper T cell-dependent immune responses in vivo. J Immunol (1994) 2.11
The international epidemiology of AIDS. Sci Am (1988) 2.08
Secondary neoplasms of the breast: a survey of the 20th Century. Cancer (2001) 2.07
Reciprocal control of RNA-binding and aconitase activity in the regulation of the iron-responsive element binding protein: role of the iron-sulfur cluster. Proc Natl Acad Sci U S A (1992) 2.06
Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis. J Clin Invest (1984) 2.03
Retracted The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity (1998) 2.02
High-intensity focused ultrasound for prostate cancer: a systematic review. Clin Oncol (R Coll Radiol) (2010) 2.02
A prospective study of surgeon-performed ultrasound as the primary adjuvant modality for injured patient assessment. J Trauma (1995) 2.01
Older people with impaired mobility have specific loci of periventricular abnormality on MRI. Neurology (2002) 2.00
The role of ultrasound in patients with possible penetrating cardiac wounds: a prospective multicenter study. J Trauma (1999) 1.89
Heterogeneity of helper/inducer T lymphocytes. III. Responses of IL-2- and IL-4-producing (Th1 and Th2) clones to antigens presented by different accessory cells. J Immunol (1990) 1.89
B-cell stimulatory factor 1 and not interleukin 2 is the autocrine growth factor for some helper T lymphocytes. Proc Natl Acad Sci U S A (1987) 1.85
Filter paper disc method of collecting whole blood for serologic studies in children. Am J Epidemiol (1966) 1.82
Molecular characterization of a second iron-responsive element binding protein, iron regulatory protein 2. Structure, function, and post-translational regulation. J Biol Chem (1994) 1.79
Retracted Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes. Immunity (1999) 1.78
Heterogeneity of helper/inducer T lymphocytes. II. Effects of interleukin 4- and interleukin 2-producing T cell clones on resting B lymphocytes. J Exp Med (1988) 1.76
Characterization and quantitation of NF-kappaB nuclear translocation induced by interleukin-1 and tumor necrosis factor-alpha. Development and use of a high capacity fluorescence cytometric system. J Biol Chem (1998) 1.73
Aqueous antigens induce in vivo tolerance selectively in IL-2- and IFN-gamma-producing (Th1) cells. J Immunol (1992) 1.73
Honey and other environmental risk factors for infant botulism. J Pediatr (1979) 1.68
CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells. J Virol (2001) 1.66
Interleukin 1 beta is localized in the cytoplasmic ground substance but is largely absent from the Golgi apparatus and plasma membranes of stimulated human monocytes. J Exp Med (1988) 1.66
Antigen presentation by hapten-specific B lymphocytes. II. Specificity and properties of antigen-presenting B lymphocytes, and function of immunoglobulin receptors. J Immunol (1985) 1.64
Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial. Proc Natl Acad Sci U S A (2001) 1.63
The role of CTLA-4 in regulating Th2 differentiation. J Immunol (1999) 1.62
Stability of Th1 and Th2 populations. Int Immunol (1995) 1.61
Country-specific estimates and models of HIV and AIDS: methods and limitations. AIDS (1999) 1.61
In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen. J Exp Med (1993) 1.57
Immunocytochemical detection of interleukin 1 within stimulated human monocytes. J Exp Med (1986) 1.57
Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution. Infect Immun (1990) 1.55
Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol (2000) 1.54
Surgeon-performed ultrasound for the assessment of truncal injuries: lessons learned from 1540 patients. Ann Surg (1998) 1.53
Diagnostic screening of mitochondrial DNA mutations in Australian adults 1990-2001. Intern Med J (2004) 1.53
Botulism--diagnosis, management and public health considerations. Calif Med (1973) 1.52
Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. J Immunol (1999) 1.51
Amino acid sequence analysis of human interleukin 1 (IL-1). Evidence for biochemically distinct forms of IL-1. J Exp Med (1985) 1.51
Public health implications of rubella antibody levels in California. Am J Public Health (1982) 1.51
The role of antibodies in the rejection and enhancement of organ allografts.?7318. Adv Immunol (1976) 1.48
The interleukin-1 beta-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy. J Exp Med (1995) 1.47
T cell responses in calcineurin A alpha-deficient mice. J Exp Med (1996) 1.44
IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. J Immunol (1996) 1.42
Mutations of immunoglobulin transmembrane and cytoplasmic domains: effects on intracellular signaling and antigen presentation. Cell (1990) 1.42
Monoclonal antibodies against rat glomerular antigens: production and specificity. Lab Invest (1983) 1.40
Modified-peptide inhibitors of amyloid beta-peptide polymerization. Biochemistry (1999) 1.40
Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model. Curr Opin Immunol (1994) 1.40
The murine IL 2 receptor. III. Cellular requirements for the induction of IL 2 receptor expression on T cell subpopulations. J Immunol (1985) 1.40
Purification and partial biochemical characterization of normal human interleukin 1. J Exp Med (1984) 1.40
Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy. J Urol (2003) 1.40
Infant botulism: epidemiology and relation to sudden infant death syndrome. Epidemiol Rev (1981) 1.38
Interrelationships of surface immunoglobulin and Fc receptors on mouse B lymphocytes. J Immunol (1975) 1.38
Idiotype-specific T cell immunity. I. Generation of effector and suppressor T lymphocytes reactive with myeloma idiotypic determinants. J Immunol (1980) 1.35
Functional heterogeneity among human inducer T cell clones. J Immunol (1988) 1.34
Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86. J Immunol (1997) 1.34
The effects of the dual 5alpha-reductase inhibitor dutasteride on localized prostate cancer--results from a 4-month pre-radical prostatectomy study. Prostate (2006) 1.33
T-cell stimulation: an abundance of B7s. Nat Med (1999) 1.32
Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor. J Immunol (1997) 1.32
Role of Fas-mediated cell death in the regulation of immune responses. Curr Opin Immunol (1996) 1.31
Immunodeficiency in graft-versus-host disease. I. Mechanism of immune suppression. J Immunol (1988) 1.30
Association of murine CD31 with transmigrating lymphocytes following antigenic stimulation. Am J Pathol (1992) 1.30
Review of AIDS and HIV infection: global epidemiology and statistics. AIDS (1989) 1.30
Specificity of a monoclonal antibody for the NH2-terminal region of fibrin. Mol Immunol (1984) 1.29
IL-1 beta-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor. J Immunol (1994) 1.28
Cytokine transcriptional events during helper T cell subset differentiation. J Exp Med (1996) 1.23
Phosphorylation of the major heat shock protein of Dictyostelium discoideum. Mol Cell Biol (1982) 1.23